AegirBio AB (AegirBio AB) Long-Term Debt : $3.25 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Long-Term Debt?

AegirBio AB's Long-Term Debt for the quarter that ended in Mar. 2024 was $3.25 Mil.

AegirBio AB's quarterly Long-Term Debt increased from Sep. 2023 ($3.01 Mil) to Dec. 2023 ($3.13 Mil) and increased from Dec. 2023 ($3.13 Mil) to Mar. 2024 ($3.25 Mil).

AegirBio AB's annual Long-Term Debt declined from Dec. 2021 ($0.93 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($3.13 Mil).

AegirBio AB Long-Term Debt Historical Data

The historical data trend for AegirBio AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Long-Term Debt Chart

AegirBio AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

0.93

3.13

AegirBio AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial													-	2.93	3.01	3.13	3.25

AegirBio AB (GREY:AEGBF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

AegirBio AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

AegirBio AB (AegirBio AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

AEGIR:Sweden 52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines